STOCK TITAN

Chilean Cobalt Corp. (COBA) boosts CEO, CFO pay in updated resale filing

(Neutral)
(Neutral)
Form Type
424B3

Rhea-AI Filing Summary

Chilean Cobalt Corp. filed a prospectus supplement updating its existing resale registration covering up to 39,000,000 shares of common stock at $1.33 per share, to be resold by selling stockholders named in the accompanying prospectus. The supplement incorporates a recent Current Report on Form 8-K.

The incorporated 8-K describes Board-approved compensation changes effective August 2026. CEO Duncan T. Blount’s annual base salary increases from $150,000 to $162,000, and his monthly maximum medical premium reimbursement rises from $2,083 to $2,583. CFO Jim Van Horn’s annual base salary increases from $112,000 to $124,000. The Board also approved a $7,000 discretionary bonus to each of Mr. Blount and Mr. Van Horn in the current month. The company characterizes investment in its common stock as speculative and subject to a high degree of risk.

Positive

  • None.

Negative

  • None.

Filing Explained

This filing updates the resale registration for up to 39,000,000 shares, but registration alone does not establish that the shares were sold or that the company received proceeds; the holder-impacting change is resale eligibility, not a reported new issuance.

Registered for resale 39,000,000 shares of common stock Shares covered by the resale prospectus
Per-share amount $1.33 per share Common stock amount referenced in the prospectus
CEO base salary (before increase) $150,000 CEO annual base salary prior to August 2026
CEO base salary (after increase) $162,000 CEO annual base salary beginning August 2026
CEO medical reimbursement cap (before) $2,083 per month Monthly maximum allowable reimbursement for medical premiums
CEO medical reimbursement cap (after) $2,583 per month Monthly maximum allowable reimbursement for medical premiums
CFO base salary (before increase) $112,000 CFO annual base salary prior to August 2026
CFO base salary (after increase) $124,000 CFO annual base salary beginning August 2026
Executive discretionary bonus $7,000 Bonus to each of the CEO and CFO in the current month
prospectus supplement regulatory
"This prospectus supplement No. 33 amends and supplements the prospectus"
A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.
selling stockholders financial
"relating to the resale of up to 39,000,000 shares... by the selling stockholders"
Selling stockholders are existing owners of a company's shares who are offering some or all of their holdings for sale, often as part of a public offering or secondary transaction. For investors this matters because such sales increase the number of shares available to buy, can signal how confident current owners are about future prospects, and may put short-term pressure on the stock price similar to more tickets being released for a popular event.
emerging growth company regulatory
"Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
discretionary bonus financial
"the Board approved payment of a $7,000 discretionary bonus"
Offering Type secondary

FAQ

What does Chilean Cobalt Corp. (COBA) register in this prospectus supplement?

The supplement relates to the resale of up to 39,000,000 shares of common stock at $1.33 per share by selling stockholders named in the accompanying prospectus.

Is the Chilean Cobalt Corp. (COBA) offering a primary sale of new shares?

No. The prospectus supplement describes a resale of shares by selling stockholders under an existing registration, rather than a new primary issuance by Chilean Cobalt Corp.

How is the CEO’s compensation changing at Chilean Cobalt Corp. (COBA)?

Effective August 2026, CEO Duncan T. Blount’s annual base salary increases from $150,000 to $162,000, and his monthly medical premium reimbursement cap rises from $2,083 to $2,583.

What salary adjustment did the CFO of Chilean Cobalt Corp. (COBA) receive?

Effective August 2026, CFO Jim Van Horn’s annual base salary increases from $112,000 to $124,000, reflecting Board-approved changes to his compensation package.

Did Chilean Cobalt Corp. (COBA) award bonuses to its executives?

Yes. The Board approved a $7,000 discretionary bonus in the current month for each of CEO Duncan T. Blount and CFO Jim Van Horn, in addition to their salary adjustments.

What risk characterization does Chilean Cobalt Corp. (COBA) give its common stock?

The company states that investing in its common stock should be considered speculative and involves a high degree of risk, including the risk of losing an investor’s entire investment.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

Filed Pursuant to Rule 424(b)(3)

Registration No. 333-268335

 

Prospectus Supplement No. 33

to Prospectus dated February 3, 2023

 

CHILEAN COBALT CORP.

 

39,000,000 Shares of Common Stock

 

$1.33 per Share

 

This prospectus supplement No. 33 amends and supplements the prospectus dated February 3, 2023, which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 333-268335) (the “Registration Statement”) and prospectus supplement No. 1 filed on March 24, 2023, prospectus supplement No. 2 filed on May 8, 2023, prospectus supplement No. 3 filed on May 15, 2023, prospectus supplement No. 4 filed on July 6, 2023, prospectus supplement No. 5 filed on July 12, 2023, prospectus supplement No. 6 filed on August 14, 2023, prospectus supplement No. 7 filed on September 27, 2023, prospectus supplement No. 8 filed on November 9, 2023, prospectus supplement No. 9 filed on February 7, 2024, prospectus supplement No. 10 filed on April 1, 2024, prospectus supplement No. 11 filed on May 8, 2024, prospectus supplement No. 12 filed on May 20, 2024, prospectus supplement No. 13 filed on June 14, 2024, prospectus supplement No. 14 filed on August 19, 2024, prospectus supplement No. 15 filed on November 14, 2024, prospectus supplement No. 16 filed on January 3, 2025, prospectus supplement No. 17 filed on February 27, 2025, prospectus supplement No. 18 filed on April 2, 2025, prospectus supplement No. 19 filed on May 15, 2025, prospectus supplement No. 20 filed on July 24, 2025, prospectus supplement No. 21 filed on July 29, 2025, prospectus supplement No. 22 filed on August 14, 2025, prospectus supplement No. 23 filed on September 3, 2025, prospectus supplement No. 24 filed on September 15, 2025, prospectus supplement No. 25 filed on November 17, 2025, prospectus supplement No. 26 filed on December 2, 2025, prospectus supplement No. 27 filed on January 5, 2026, prospectus supplement No. 28 filed on March 20, 2026, prospectus supplement No. 29 filed on March 31, 2026, prospectus supplement No. 30 filed on May 20, 2026, prospectus supplement No. 31 filed on May 21, 2026 and prospectus supplement No. 32 filed on July 22, 2026 (collectively, the “Supplements”) relating to the resale of up to 39,000,000 shares of common stock of Chilean Cobalt Corp. (the “Company,” “C3,” “we,” “our” and “us”) by the selling stockholders named in the prospectus. The foregoing prospectus, the Supplements and this prospectus supplement No. 33 are collectively referred to as the “prospectus.” Please keep this prospectus supplement with your prospectus for future reference.

 

This prospectus supplement incorporates into the prospectus the attached Current Report on Form 8-K, filed with the Securities and Exchange Commission (“SEC”) on August 13, 2026.

 

This prospectus supplement is not complete without the prospectus, including any supplements and amendments thereto. This prospectus supplement should be read in conjunction with the prospectus which is to be delivered with this prospectus supplement. This prospectus supplement is qualified by reference to the prospectus, except to the extent that the information in this prospectus supplement updates or supersedes the information contained in the prospectus, including any supplements and amendments thereto.

 

Investing in our common stock should be considered speculative and involves a high degree of risk, including the risk of losing your entire investment. See Risk Factors section of the prospectus to read about the risks you should consider before buying shares of our common stock.

 

Neither the SEC nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

 

Capitalized terms contained in this prospectus supplement have the same meanings as in the prospectus unless otherwise stated herein.

 

The date of this prospectus supplement is August 13, 2026

 

 

 

   

 

 

Index of SEC Filings

 

The following report listed below is filed as a part of this prospectus supplement No. 33.

 

Appendix No.   Description
     
Appendix 1   Current Report on Form 8-K, filed with the Securities and Exchange Commission on August 13, 2026.

 

 

 

 

 

 

 

 

 

 

 

 

 

 2 

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): August 7, 2026

 

CHILEAN COBALT CORP.

(Exact name of registrant as specified in its charter)

 

Nevada   333-268335   82-3590294

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification Number)

 

1199 Lancaster Ave, Suite 107

Berwyn, Pennsylvania 19312

(Address of principal executive offices)

 

(484) 580-8697

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions.

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class  

Trading Symbol(s)

  Name of each exchange on which registered
None.        

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

   

 

 

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On August 7, 2026, the Board of Directors (the “Board”) of Chilean Cobalt Corp. (the “Company”) approved certain changes to the compensation packages of Duncan T. Blount, the Company’s Chief Executive Officer, President and Chairperson of the Board, and Jim Van Horn, the Company’s Chief Financial Officer, effective with the current month.

 

Beginning with the month of August 2026, (i) Mr. Blount’s annual base salary will increase from $150,000 to $162,000; (ii) Mr. Blount’s monthly maximum allowable reimbursement for medical premiums will increase from $2,083 per month to $2,583; and (iii) Mr. Van Horn’s annual base salary will increase from $112,000 to $124,000. In addition, the Board approved payment of a $7,000 discretionary bonus to each of Mr. Blount and Mr. Van Horn in the current month.

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  CHILEAN COBALT CORP
   
Dated: August 13, 2026 By: /s/ Duncan T. Blount
  Name: Duncan T. Blount
  Title: Chief Executive Officer

 

 

 

 2